- Special Sections
- Public Notices
Q: I heard that a new drug was approved for age-related macular degeneration. What can you tell me about it?
A: The FDA recently approved a new drug therapy to help slow vision loss in people with the eye disease known as neovascular (wet) age-related macular degeneration or AMD.
AMD occurs when the central part of the eye’s retina, known as the macula, is damaged. This can lead to severe, irreversible loss of vision and is the leading cause of severe vision loss in people older than 50.
If you currently subscribe or have subscribed in the past to the Citrus Chronicle, then simply find your account number on your mailing label and enter it below.
Click the question mark below to see where your account ID appears on your mailing label.